Titleist Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Titleist Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$617K	Sell	2,933 -581	-17%	-$117K	0.04%	260
2026 Q2	$668K	Buy	3,514 +259	+8%	+$44.5K	0.05%	241
2026 Q1	$550K	Buy	3,255 +411	+14%	+$70.3K	0.04%	244
2025 Q4	$480K	Buy	+2,844	New	+$462K	0.04%	230

Other funds holding IBB

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return

MCM

Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return

CCA

Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

AIM

Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

KIG

Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return

Titleist Asset Management's IBB Position: Q3 2026 in Review

Titleist Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 17% in Q3 2026, selling an estimated $117K and leaving 2,933 shares worth $617K. The position accounts for 0.04% of the portfolio, ranked #260.

Titleist Asset Management first reported a position in IBB in Q4 2025 and has held it in 4 quarters since. The position peaked at $668K in Q2 2026. 40 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Titleist Asset Management held 2,933 shares of iShares Biotechnology ETF worth $617K as of Q3 2026.
Titleist Asset Management sold 581 iShares Biotechnology ETF shares in Q3 2026, an estimated $117K.
iShares Biotechnology ETF made up 0.04% of Titleist Asset Management's portfolio in Q3 2026, its #260 holding.
Titleist Asset Management first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 4 quarters since.
Titleist Asset Management's iShares Biotechnology ETF position peaked at $668K in Q2 2026.
40 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Titleist Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.